Literature DB >> 739288

Angiogenic activity in culture supernatant of antigen-stimulated lymph node cells.

K Nishioka, I Katayama.   

Abstract

The culture supernatant of antigen- and phytohaemagglutinin-stimulated lymph node cells contained angiogenic activity when applied to hamster cheek pouch vascular membranes. New capillary growth was observed about 7 days after such application. This activity was generated by culturing lymph node cells with antigens for at least 12 hr, while migration inhibitory factor (MIF) was detected in the culture supernatant of 6 hr cultures. The angiogenic activity was separated from blastogenic activity, clot-promoting activity and antibody activity. However, it was not completely separated from MIF by gel-filtration. The molecular weight of the angiogenic activity was estimated to be between 35,000 and 55,000 daltons.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 739288     DOI: 10.1002/path.1711260202

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas.

Authors:  J W Moore; M M Sholley
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

2.  Inducement of blood vessel formation by ovarian extracts from mice injected with gonadotropins.

Authors:  E Sato; T Ishibashi; S S Koide
Journal:  Experientia       Date:  1982-10-15

Review 3.  Vascularization of tumors: a review.

Authors:  P Shubik
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  Angiogenic activity from bovine retina: partial purification and characterization.

Authors:  P A D'Amore; B M Glaser; S K Brunson; A H Fenselau
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  Regulation of lymph node vascular growth by dendritic cells.

Authors:  Brian Webster; Eric H Ekland; Lucila M Agle; Susan Chyou; Regina Ruggieri; Theresa T Lu
Journal:  J Exp Med       Date:  2006-07-10       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.